# Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products, Division 1: Qualitative particulars

Extent: E+W+S+N.I.

‘ Qualitative particulars ’ of all the constituents of the immunological veterinary medicinal product shall mean the designation or description of:
the active substance(s),
the constituents of the adjuvants,
the constituent(s) of the excipients, whatever their nature or the quantity used, including preservatives, stabilisers, emulsifiers, colouring matter, flavouring, aromatic substances, markers, etc.,
the constituents of the pharmaceutical form administered to animals.
These particulars shall be supplemented by any relevant data concerning the container and, where appropriate, its manner of closure, together with details of devices with which the immunological veterinary medicinal product will be used or administered and which will be delivered with the medicinal product. If the device is not delivered together with the immunological veterinary medicinal product, relevant information about the device shall be provided, where necessary for the assessment of the product.

---
Source: https://www.legislation.gov.uk/eudr/2001/82/annex/I/title/II/part/2/division/A/division/1 (the official version)
Page: https://openlegislation.uk/eu-directive-2001-82/annex-I/title-II/part-2/division-A/division-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.